DGAP-News: RHÖN-KLINIKUM AG witnesses pleasing Q2 growth
(firmenpresse) - DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Half Year Results
RHÖN-KLINIKUM AG witnesses pleasing Q2 growth
08.08.2013 / 07:00
---------------------------------------------------------------------
Press Release
RHÖN-KLINIKUM AG Schlossplatz 1 D-97616 Bad Neustadt a. d. Saale
http://www.rhoen-klinikum-ag.com
RHÖN-KLINIKUM AG witnesses pleasing Q2 growth
- RHÖN?KLINIKUM AG reports growth of 7.1% growth in patient numbers
versus H1 of previous year
- Revenues increase by 8.4% to more than EUR 1.5 billion
- Net consolidated profit for H1 of 2013 amounts to EUR 50.8 million
(same period last year: EUR 50.3 million). EBITDA climbs by 4.1% to
reach EUR 151.5 million.
- Outlook for full year confirmed
Bad Neustadt a. d. Saale, 8 August 2013
Patient numbers and revenues at the Group of RHÖN-KLINIKUM AG witnessed
further growth in the first half of 2013. In the first six months 1,346,258
patients were treated, 7.1% more than over the same period of the previous
year. Revenues climbed by 8.4% to reach EUR 1.507 billion. The pleasing
organic growth in revenues was further helped by the consolidation of Dr.
Horst Schmidt Kliniken (HSK) in Wiesbaden.
EBITDA grew in the first three quarters of 2013 by 4.1% to EUR 151.5
million. EBIT increased over the same period by 5.6% to EUR 81.4 million.
During the reporting period, net consolidated profit stood at EUR 50.8
million, and was thus 1.0% above the level of the same period in 2012.
After deducting non-controlling interests in profit of EUR 1.9 million from
net consolidated profit, earnings per ordinary share stood at EUR 0.35 for
the first six months.
'As the figures of the first half of 2013 show, RHÖN-KLINIKUM AG is well on
its way to achieving its traditionally strong results', said Dr. Martin
Siebert, chairman of the Board of Management of RHÖN-KLINIKUM AG. 'The
integration of Dr. Horst Schmidt Kliniken in Wiesbaden and the further
development of our Gießen and Marburg University Hospital are proceeding in
line with the goals set in terms of the timetable and action plan.'
At the beginning of June, the Board of Management gave the go-ahead for the
comprehensive and Group-wide growth and transformation programme 'ImPULS'.
Under 'ImPULS', the primary objective is to gain market shares thanks to an
even better care offering for our patients and within the framework of a
quality offensive. 'The rising earnings strength to be brought about under
the 'ImPULS' programme will enable us at the same time to make targeted
investments over the next few years to shape up our sites for the future
network-based care concepts both structurally and technologically' adds
Jens-Peter Neumann, the Group's CFO.
Against this background, the Company is expecting organic growth rates over
the medium term to the tune of roughly 3.5% to 4.5% p.a. Building on
'ImPULS', it appears realistic, based on the current portfolio of
facilities - i.e. without further acquisitions or structural measures -, to
achieve an EBITDA margin of above 12% for the Group overall by 2015. On its
path towards becoming an integrated health company, RHÖN-KLINIKUM AG, by
extending the office terms of the two members of the Board of Management,
Jens-Peter Neumann and Martin Menger, is moreover underscoring the
importance of continuity.
For full-year 2013, the Company continues to expect revenues of EUR 3.03
billion which may fluctuate within a range of plus or minus 2.5%. Moreover,
EBITDA is expected to reach EUR 325 million and net consolidated profit EUR
110 million. These figures may fluctuate within a range of plus or minus
5%.
**************************************************************************
*************
RHÖN-KLINIKUM AG is one of the largest healthcare providers in Germany. Its
corporate objective is high-quality medical care for everyone. Currently,
our Group counts 54 hospitals at 43 sites throughout Germany. We employ
roughly 43,000 persons. In financial year 2012, more than 2.5 million
patients were treated in the Group's facilities.
Further information is available at: www.rhoen-klinikum-ag.com.
Contact:
RHÖN-KLINIKUM AG
Sascha Schiffler
Head of Group Press and Public Relations
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telephone: 09771 65-1327
Fax: 09771 65-1820
E-mail: kommunikation(at)rhoen-klinikum-ag.com
Dr. Kai G. Klinger
Head of Investor Relations
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telephone: 09771 65-1318
Fax: 09771 99-1736
E-mail: ir(at)rhoen-klinikum-ag.com
End of Corporate News
---------------------------------------------------------------------
08.08.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: rka(at)rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: MDAX
Listed: Regulierter Markt in Frankfurt (Prime Standard), München;
Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
224795 08.08.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.08.2013 - 07:00 Uhr
Sprache: Deutsch
News-ID 285802
Anzahl Zeichen: 17713
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 410 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: RHÖN-KLINIKUM AG witnesses pleasing Q2 growth"
steht unter der journalistisch-redaktionellen Verantwortung von
RHÖN-KLINIKUM AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
